Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Neoplasms 3Osteosarcoma 2Triple Negative Breast Neoplasms 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Pathologic Complete Response 1Ovarian Carcinosarcoma 1Neuroblastoma 1Neoplasm Metastasis 1Melanoma 1Hodgkin Disease 1Hepatoblastoma 1Hemangiosarcoma 1Glioblastoma 1Fibrolamellar hepatocellular carcinoma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Carcinoma, Neuroendocrine 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Adrenocortical Carcinoma 1

Interventions

Temozolomide 4Irinotecan 3abemaciclib 2Radiotherapy 2Cyclophosphamide 2Bevacizumab 2palbociclib 1dostarlimab 1dinutuximab 1adavosertib 1Vorinostat 1Vincristine 1Valproic Acid 1Topotecan 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Mebendazole 1Granulocyte-Macrophage Colony-Stimulating Factor 1Etoposide 1Eflornithine 1Carboplatin 1CLR1404 11-methyltryptophan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diffuse Intrinsic Pontine Glioma × dostarlimab × Sarcoma × Clear all
NCT06521567 2025-11-12

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

GlaxoSmithKline

Phase 1/2 Active not recruiting
83 enrolled
CNSDermatologicGastrointestinalLymphoidSarcoma

Fibrolamellar hepatocellular carcinoma, Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Melanoma, Rhabdomyosarcoma, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡